Pancreatic Cancer Research

ResearcherSahlgrenska University HospitalActive in the last 2 years

Johan Bourghardt Fagman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1527-5280; OpenAlex author ID A5078309725. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 6

  1. Accumulation of p62/sequestosome-1 in pancreatic cancer progression: association with inflammation and immune cell infiltration. Last author DOI 10.1016/j.pan.2026.07.005↗
  2. Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-23-0447↗
  3. Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models. Co-author DOI 10.1016/j.gastha.2022.07.006↗
  4. High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer. Last author DOI 10.1186/s12885-022-09468-6↗
  5. A comprehensive review of pancreatic cancer and its therapeutic challenges. First author DOI 10.18632/aging.204310↗
  6. EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival. Co-author DOI 10.3892/ol.2019.10224↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eva Philipson · 2 shared papers, 2022–2026 · strength 0.61
  2. Svein Olav Bratlie · 1 shared paper, 2024 · strength 0.20
  3. Hanna Grauers Wiktorin · 1 shared paper, 2024 · strength 0.20
  4. Anna Martner · 1 shared paper, 2024 · strength 0.20
  5. Shan Jiang · 1 shared paper, 2022 · strength 0.16
  6. Lisa M. Nilsson · 1 shared paper, 2022 · strength 0.16
  7. Jonas A. Nilsson · 1 shared paper, 2022 · strength 0.16
  8. Changyan Chen · 1 shared paper, 2022 · strength 0.16
  9. Kent Lundholm · 1 shared paper, 2019 · strength 0.11
  10. David Ljungman · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.